Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

A MELAS syndrome family harboring two mutations in mitochondrial genome.

Authors: Choi, BO  Hwang, JH  Kim, J  Cho, EM  Cho, SY  Hwang, SJ  Lee, HW  Kim, SJ  Chung, KW 
Citation: Choi BO, etal., Exp Mol Med. 2008 Jun 30;40(3):354-60.
Pubmed: (View Article at PubMed) PMID:18587274
DOI: Full-text: DOI:10.3858/emm.2008.40.3.354

Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a genetically heterogeneous mitochondrial disorder with variable clinical symptoms. Here, from the sequencing of the entire mitochondrial genome, we report a Korean MELAS family harboring two homoplasmic missense mutations, which were reported 9957T>C (Phe251Leu) transition mutation in the cytochrome c oxidase subunit 3 (COX3) gene and a novel 13849A>C (Asn505His) transversion mutation in the NADH dehydrogenase subunit 5 (ND5) gene. Neither of these mutations was found in 205 normal controls. Both mutations were identified from the proband and his mother, but not his father. The patients showed cataract symptom in addition to MELAS phenotype. We believe that the 9957T>C mutation is pathogenic, however, the 13849A>C mutation is of unclear significance. It is likely that the 13849A>C mutation might function as the secondary mutation which increase the expressivity of overlapping phenotypes of MELAS and cataract. This study also demonstrates the importance of full sequencing of mtDNA for the molecular genetic understanding of mitochondrial disorders.


Disease Annotations
Objects Annotated

Additional Information

CRRD Object Information
CRRD ID: 5491184
Created: 2011-09-30
Species: All species
Last Modified: 2011-09-30
Status: ACTIVE


RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.